Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -6.176\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. COc1cccc(CCc2nnc(CCC(=O)N3CCCC3c3nccs3)o2)c1
b. O=C(CNC(=O)C1CCCCC1)NC1CCCCC1
c. Cc1ccccc1OCC(=O)N(Cc1nnc(-c2ccc(Cl)cc2)o1)C(C)C
Answer: c. Cc1ccccc1OCC(=O)N(Cc1nnc(-c2ccc(Cl)cc2)o1)C(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccccc1OCC(=O)N(Cc1nnc(-c2ccc(Cl)cc2)o1)C(C)C
Cc1ccccc1OCC(=O)N(Cc1nnc(-c2ccc(Cl)cc2)o1)C(C)C
N-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl]-2-(2-methylphenoxy)-N-propan-2-ylacetamide